Source: Fundamental and Clinical Pharmacology. Unidade: FM
Subjects: FÁRMACOS SINTÉTICOS, LÍQUIDO AMNIÓTICO, INIBIDORES DE ENZIMAS, DIFERENCIAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANZ, Felipe de Lara et al. Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC). Fundamental and Clinical Pharmacology, v. 28, n. 2, p. 211-216, 2014Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/fcp.12006/pdf. Acesso em: 14 nov. 2024.APA
Janz, F. de L., Favero, G. M., Bohatch Jr., M. S., Debes, A. A., & Bydlowski, S. P. (2014). Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC). Fundamental and Clinical Pharmacology, 28( 2), 211-216. doi:10.1111/fcp.12006NLM
Janz F de L, Favero GM, Bohatch Jr. MS, Debes AA, Bydlowski SP. Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC) [Internet]. Fundamental and Clinical Pharmacology. 2014 ; 28( 2): 211-216.[citado 2024 nov. 14 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/fcp.12006/pdfVancouver
Janz F de L, Favero GM, Bohatch Jr. MS, Debes AA, Bydlowski SP. Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC) [Internet]. Fundamental and Clinical Pharmacology. 2014 ; 28( 2): 211-216.[citado 2024 nov. 14 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/fcp.12006/pdf
